首页> 外文期刊>Acta biomaterialia >Functional fabrication of recombinant human collagen-phosphorylcholine hydrogels for regenerative medicine applications
【24h】

Functional fabrication of recombinant human collagen-phosphorylcholine hydrogels for regenerative medicine applications

机译:用于再生医学应用的重组人胶原蛋白-磷酸胆碱水凝胶的功能制备

获取原文
获取原文并翻译 | 示例
       

摘要

The implant-host interface is a critical element in guiding tissue or organ regeneration. We previously developed hydrogels comprising interpenetrating networks of recombinant human collagen type III and 2-methacryloyloxyethyl phosphorylcholine (RHCIII-MPC) as substitutes for the corneal extracellular matrix that promote endogenous regeneration of corneal tissue. To render them functional for clinical application, we have now optimized their composition and thereby enhanced their mechanical properties. We have demonstrated that such optimized RHCIII-MPC hydrogels are suitable for precision femtosecond laser cutting to produce complementing implants and host surgical beds for subsequent tissue welding. This avoids the tissue damage and inflammation associated with manual surgical techniques, thereby leading to more efficient healing. Although we previously demonstrated in clinical testing that RHCIII-based implants stimulated cornea regeneration in patients, the rate of epithelial cell coverage of the implants needs improvement, e.g. modification of the implant surface. We now show that our 500 mu m thick RHCIII-MPC constructs comprising over 85% water are suitable for microcontact printing with fibronectin. The resulting fibronectin micropatterns promote cell adhesion, unlike the bare RHCIII-MPC hydrogel. Interestingly, a pattern of 30 mu m wide fibronectin stripes enhanced cell attachment and showed the highest mitotic rates, an effect that potentially can be utilized for faster integration of the implant. We have therefore shown that laboratory-produced mimics of naturally occurring collagen and phospholipids can be fabricated into robust hydrogels that can be laser profiled and patterned to enhance their potential function as artificial substitutes of donor human corneas. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd.
机译:植入物-宿主界面是引导组织或器官再生的关键要素。我们以前开发的水凝胶包含重组人III型胶原蛋白和2-甲基丙烯酰氧基乙基磷酰胆碱(RHCIII-MPC)的互穿网络,以替代促进角膜组织内源性再生的角膜细胞外基质。为了使其具有临床应用功能,我们现在优化了它们的组成,从而增强了它们的机械性能。我们已经证明,这种优化的RHCIII-MPC水凝胶适用于精密飞秒激光切割,以产生互补的植入物并为随后的组织焊接提供宿主手术床。这避免了与手工手术技术相关的组织损伤和炎症,从而导致更有效的愈合。尽管我们先前在临床测试中证明基于RHCIII的植入物刺激了患者的角膜再生,但该植入物的上皮细胞覆盖率仍需要提高,例如植入物表面的修饰。现在我们表明,我们的500微米厚的RHCIII-MPC构建体包含超过85%的水,适合与纤连蛋白进行微接触印刷。与裸露的RHCIII-MPC水凝胶不同,所得的纤连蛋白微模式可促进细胞粘附。有趣的是,30微米宽的纤连蛋白条纹图案增强了细胞附着并显示出最高的有丝分裂率,这种效果可能可以用于植入物的更快整合。因此,我们已经表明,可以将实验室生产的天然存在的胶原蛋白和磷脂的模拟物制成坚固的水凝胶,可以对其进行激光分析和图案化,以增强其作为供体人类角膜的人工替代品的潜在功能。 (C)2014 Acta Materialia Inc.,由Elsevier Ltd.发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号